An artificial intelligence-based quality assurance pipeline could detect missed intestinal metaplasia in as many as 1.5% of gastric biopsy specimens, highlighting a potentially addressable diagnostic gap. An automated pipeline could additionally provide quantitative information that could be informative for management.
Willis et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: